BAB V KESIMPULAN DAN SARAN
5.2. Saran
1. Bagi penelitian selanjutnya agar melakukan analisis hubungan antara berbagai karakteristik yang telah ditemukan peneliti dengan tingkat
keparahan COVID-19 menggunakan desain penelitian untuk mengetahui hubungan sebab-akibat antar variabel, seperti case control dan kohort 2. Bagi klinisi agar dapat mengidentifikasi berbagai karakteristik yang telah
diteliti pada penelitian ini pada tiap pasien ibu hamil yang mengalami COVID-19, sehingga tata laksana yang sesuai dapat diberikan
59
DAFTAR PUSTAKA
1. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, et al. COVID-19: towards controlling of a pandemic. The Lancet. 2020.
2. Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Pandemic (COVID-19). Our World Data [Internet]. 2020 Mar 4 [cited 2021 Feb 25];
Available from: https://ourworldindata.org/coronavirus
3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020.
4. Tripathi S, Gogia A, Kakar A. COVID-19 in pregnancy: A review. J Family Med Prim Care. 2020;9(9):4536.
5. Capobianco G, Saderi L, Aliberti S, Mondoni M, Piana A, Dessole F, et al.
COVID-19 in pregnant women: A systematic review and meta-analysis.
European Journal of Obstetrics and Gynecology and Reproductive Biology.
2020 Sep 1;252:543–58.
6. Yuliana LW. Karakteristik gejala klinis kehamilan dengan Coronavirus disease (COVID-19). Jurnal Ilmiah Kesehatan Sandi Husada. 2020 Dec 31;12(2):726–34.
7. Suganthan N. Covid-19. Jaffna Medical Journal. 2019;
8. Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Pandemic (COVID-19). Our World in Data. 2020 Mar 4;
9. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA - Journal of the American Medical Association. 2020.
10. Viceconte G, Petrosillo N. COVID-19 R0: Magic number or conundrum?
Infect Dis Rep. 2020;
11. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. The BMJ. 2020 Oct 23;371.
12. Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL, et al.
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature.
2020;583(7818).
13. Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, et al.
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4).
14. Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19.
Vol. 53, Immunity. 2020.
15. Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al.
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis.
2020;20(10).
16. Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 2020;57.
17. Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19:
Implications for the Cardiovascular System. Circulation. 2020.
18. Perera RAPM, Mok CKP, Tsang OTY, Lv H, Ko RLW, Wu NC, et al.
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Eurosurveillance. 2020;25(16).
19. Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al.
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12).
20. Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7).
21. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol. 2020;
22. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol. 2020;
23. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. Nature Research; 2020. p. 1–2.
24. Raoult D, Hsueh PR, Stefani S, Rolain JM. COVID-19 Therapeutic and Prevention. International Journal of Antimicrobial Agents. 2020.
25. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;
26. Mathad JS, Gupta A. Pulmonary Infections in Pregnancy. Semin Respir Crit Care Med. 2017 Apr 1;38(2):174–84.
27. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. The BMJ. 2020 Sep 1;370.
28. Cohen J, Vignaux O, Jacquemard F. Covid-19 in pregnant women: General data from a French National Survey. Vol. 251, European Journal of Obstetrics and Gynecology and Reproductive Biology. Elsevier Ireland Ltd;
2020. p. 267–8.
29. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020 Sep 4;25(1).
30. Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) Pneumonia: A preliminary analysis. American Journal of Roentgenology. 2020 Jul 1;215(1):127–32.
31. Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R.
Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women:
A systematic review. International Journal of Gynecology and Obstetrics.
2020 Oct 1;151(1):7–16.
32. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020. Morbidity and Mortality Weekly Report. 2020 Nov 6;69(44):1641.
33. Tutiya C, Mello F, Chaccur G, Almeida C, Galvão E, Barbosa de Souza AC, et al. Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil. https://doi.org/101080/1476705820211880561.
2021;
34. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ.
COVID-19: consider cytokine storm syndromes and immunosuppression.
Vol. 395, The Lancet. 2020.
35. Trevisan C, Noale M, Prinelli F, Maggi S, Sojic A, Di Bari M, et al. Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey. Eur J Intern Med. 2021 Apr 1;86:41.
36. Sakowicz A, Ayala AE, Ukeje CC, Witting CS, Grobman WA, Miller ES.
Risk factors for severe acute respiratory syndrome coronavirus 2 infection in pregnant women. Am J Obstet Gynecol MFM. 2020 Nov 1;2(4):100198.
37. Di Martino D, Chiaffarino F, Patanè L, Prefumo F, Vergani P, Ornaghi S, et al. Assessing risk factors for severe forms of COVID-19 in a pregnant population: A clinical series from Lombardy, Italy. International Journal of Gynecology and Obstetrics. 2021;152(2).
38. Savasi VM, Parisi F, Patanè L, Ferrazzi E, Frigerio L, Pellegrino A, et al.
Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19). Obstetrics and Gynecology.
2020;136(2).
39. Usul E, San I, Bekgöz B, Sahin A. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark Med. 2020;14(13).
40. Karimi Shahri M, Niazkar HR, Rad F. COVID-19 and hematology findings based on the current evidences: A puzzle with many missing pieces. Vol. 43, International Journal of Laboratory Hematology. 2021.
41. Benoit JL, Benoit SW, de Oliveira MHS, Lippi G, Henry BM. Anemia and COVID‐19: A prospective perspective. J Med Virol. 2021 Feb 1;93(2):708.
42. Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber M, et al. Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection. J Clin Med. 2020 Aug 1;9(8):1–11.
43. Taneri PE, Gómez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Díaz ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020 Aug 1;35(8):763.
44. Henry BM, Benoit SW, de Oliveira MHS, Hsieh WC, Benoit J, Ballout RA, et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review. Clin Biochem.
2020 Jul 1;81:1.
45. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
The Lancet. 2020;395(10226).
46. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. The BMJ. 2020 Sep 1;370:23–30.
47. Liu W, Wang Q, Zhang Q, Chen L. Coronavirus disease 2019 (COVID-19) during pregnancy: a case series. Preprint. 2020;2019(February).
48. Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Thromb Res. 2020 Dec 1;196:99–105.
49. Biamonte F, Botta C, Mazzitelli M, Rotundo S, Trecarichi EM, Foti D, et al.
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. J Transl Med.
2021 Dec 1;19(1):1–10.
50. He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep.
2021 Dec 1;11(1):1830.
51. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020 Jul 2;14.
52. Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020 Jul 10;8(1):1–11.
53. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020 Apr 1;18(4):844–
7.
54. Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other
parameters of hemostasis. Journal of Thrombosis and Haemostasis. 2020 Jul 1;18(7):1738–42.
55. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. Journal of Heart and Lung Transplantation. 2020 May 1;39(5):405–7.
56. Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017 Jan 1;149:38–44.
57. Cozzi D, Albanesi · Marco, Cavigli · Edoardo, Chiara Moroni ·, Bindi A, Luvarà S, et al. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol Med.
2020;125(1):730–7.
58. Colombi D, Bodini FC, Petrini M, Maffi G, Morelli N, Milanese G, et al.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia. RSNA Radiology. 2020 Apr 17;296(2):E86–96.
65
66
67
68
69 00……..